Global Sinus Dilation Devices Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product Type (Balloon Sinuplasty Devices, Endoscopes, Sinus Stents), By End User (Hospitals And Clinics, Medical Stores, Others), And By Geography - Forecasts From 2021 To 2026

The sinus dilation device market is estimated to attain a market size of US$3.743 billion in 2026 from US$2.385 billion in 2019, growing at a CAGR of 6.65%. The market-driven by growing cases of chronic sinusitis. Lifestyle changes and environmental factors are the major reasons causing an increase in chronic sinus disease. Sinusitis is a common medical condition in which cavities around the nasal known as (sinuses) get inflamed. Symptoms of sinus include nasal block, tenderness, swelling of the face, sore throat, nausea, fatigue or irritability, and pain in the jaw and teeth. Sinus dilation devices are employed for the treatment of sinusitis. Sinus dilation devices, such as balloon sinuplasty systems and sinus stents, expand the sinus opening of a patient’s nose during the sinus surgery, thereby treating the drainage problem associated with the nasal sinuses.

Impact of COVID on the market.

The COVID pandemic had a significant negative impact on the market for sinus dilation devices market. Due to lockdown restrictions in various countries, the production and supply chain had been disrupted. Similar to drugs, medical devices also rely on healthcare facilities for their trial and data collection. These medical devices undergo several trials both pre-market and post-market. However post-COVID it is anticipated that the market for sinus dilation devices will revive and will witness lucrative growth in the coming years.  

Market Drivers

There has been a growing preference for minimally invasive procedures which has been driving growth in the market of sinus dilation devices. The minimally invasive surgical procedures are patient-friendly. An increase in the number of patients suffering from chronic sinusitis has led to an increase in the use of minimally invasive sinus techniques (MIST) thereby driving growth in the market.

Market Restraints:

One of the factors hampering the growth of the market is the risks associated with sinus surgeries. For example, risks associated with the procedures are bleeding, recurrent sinus infections, postoperative infections, and others.

Market Developments:

• In the year 2018, Stryker Corporation finalized its merger agreement to acquire Entellus Medical, a high-growth global medical technology company for US$ 662 million. The company Entellus Medical focuses on providing minimally invasive solutions for various ear, throat, and nose conditions.
• Intersect ENT in December 2018, announced its first patient enrolment in the company’s study of a new product platform, the ASCEND investigational drug-coated sinus balloon.
• According to the Centre for Disease Control and Prevention, nearly 11% of adults in the USA are diagnosed with sinusitis which accounts for nearly 26.9 million adults. Technological advancements over the years have helped to develop sinus dilation devices that have fewer side effects. An increase in the disposable income of the people and the affordability of the product will boost market growth.
• In February 2019, Stryker announced the acquisition of Arrinex, it is a California-based medical device company. This acquisition is expected to expand the portfolio of Stryker’s ENT Unit. 

Based on product type, the balloon sinus dilation device is estimated to be one of the major shareholders in the market of sinus dilation devices market. This product is highly demanded as compared to the others owing to the various benefits it offers. The use of these devices helps dilate obstructed sinus ostia in patients and do not need tissue or bone removal during surgery and cause less bleeding than traditional treatment procedures.

Hospitals are estimated to be one of the largest end-users of sinus dilation devices because the hospitals can afford advanced technologies. Moreover, with an increase in the number of highly equipped hospitals the demand for sinus dilation devices will also increase. 

There is a growing demand for effective technologies that will help in curing chronic sinus, thereby increasing the demand for sinus dilation devices.

North America will witness lucrative growth in the market

The North American region will hold the largest share of the market of sinus dilation devices. The major reason is that a large population in the country suffers from chronic sinus. An increase in the investment and adoption of new technologies will boost the demand for these devices in the country. Furthermore, a favourable reimbursement scenario will increase the rate of adoption of sinus procedures among the patient population.  

Japan is another emerging country that is witnessing significant growth in the market of sinus dilation devices. The climate and humidity in the country are the major reasons for the growing cases of sinus disease. Technological advancements and growing awareness about the minimum invasive procedures for treatment are some of the major reasons driving growth in the region. Improvement in healthcare facilities and huge investments will lead to lucrative growth in the Asia Pacific region. 

Major Players:

The major players in the market are Bausch Health Companies Inc., Dalent LLC, Intersect ENT Inc., Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic Plc, Olympus Corp., Smith & Nephew Plc, Stryker Corp., and TE Connectivity Ltd. The players in this market are very competitive and are taking advantage of the growing trend by launching new products and entering into mergers and acquisitions.

Global Sinus Dilation Devices Market Scope:

Report Metric	Details
Market size value in 2019	US$2.385 billion
Market size value in 2026	US$3.743 billion
Growth Rate	CAGR of 6.65% from 2019 to 2026
Base year	2019
Forecast period	2021–2026
Forecast Unit (Value)	USD Billion
Segments Covered	Product Type, End-User, And Geography
Regions covered	North America, South America, Europe, Middle East and   Africa, Asia Pacific
Companies covered	Bausch Health Companies Inc., Dalent LLC, Intersect   ENT Inc., Johnson & Johnson, KARL STORZ SE & Co.   KG,  Medtronic Plc, Olympus Corp., Smith & Nephew   Plc,  Stryker Corp., TE Connectivity Ltd.
Customization scope	Free report customization with purchase

 

Segmentation:

• By Product Type
  • Balloon Sinuplasty Devices
  • Endoscopes,
  • Sinus Stents
• By End-User
  • Hospitals and Clinics
  • Medical Stores
  • Others
• By Geography
  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Others
  • Europe
    • U.K
    • Germany
    • Italy
    • France
    • Netherlands
    • Spain
    • Others
  • Middle East and Africa
    • Israel
    • South Africa
    • Saudi Arabia
    • Others
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Others

---

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for the sinus dilation device market?
A1. The global sinus dilation device market is estimated to grow at a CAGR of 6.65% during the forecast period.

Q2. What will be the sinus dilation device market size by 2026?
A2. The sinus dilation device market is estimated to reach a market size of US$3.743 billion by 2026.

Q3. What is the size of the global sinus dilation device market?
A3. Sinus Dilation Device Market was valued at US$2.385 billion in 2019. 

Q4. Which region holds the maximum market share in the sinus dilation device market?
A4. The North American region will hold the largest share in the sinus dilation devices market owing to a large population in the country that suffers from chronic sinus.

Q5. Who are the major players in the sinus dilation device market?
A5. The major players in the sinus dilation device market are Bausch Health Companies Inc., Dalent LLC, Intersect ENT Inc., Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic Plc, Olympus Corp., Smith & Nephew Plc, Stryker Corp., and TE Connectivity Ltd.

---